273 related articles for article (PubMed ID: 30124339)
1. The use of biomarkers as a tool for novel psoriatic disease drug discovery.
Aggarwal D; Arumalla N; Jethwa H; Abraham S
Expert Opin Drug Discov; 2018 Sep; 13(9):875-887. PubMed ID: 30124339
[TBL] [Abstract][Full Text] [Related]
2. Differences between psoriatic arthritis and psoriasis in multi-omics.
Gao S; Song H
Arch Dermatol Res; 2024 May; 316(6):217. PubMed ID: 38787526
[TBL] [Abstract][Full Text] [Related]
3. Not your average joint: Towards precision medicine in psoriatic arthritis.
Castillo R; Scher JU
Clin Immunol; 2020 Aug; 217():108470. PubMed ID: 32473975
[TBL] [Abstract][Full Text] [Related]
4. Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.
Butt AQ; McArdle A; Gibson DS; FitzGerald O; Pennington SR
Curr Rheumatol Rep; 2015 May; 17(5):35. PubMed ID: 25895652
[TBL] [Abstract][Full Text] [Related]
5. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
[TBL] [Abstract][Full Text] [Related]
6. Ixekizumab for treatment of adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
Vu TT; Gooderham M; Papp K
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1423-1433. PubMed ID: 27690669
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and pharmacogenomics in psoriasis treatment: current challenges and future prospects.
Sutherland A; Power RJ; Rahman P; O'Rielly DD
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):923-35. PubMed ID: 27266955
[TBL] [Abstract][Full Text] [Related]
8. Ustekinumab for the treatment of psoriasis and psoriatic arthritis: a drug evaluation and literature review.
Thibodaux RJ; Triche MW; Espinoza LR
Expert Opin Biol Ther; 2018 Jul; 18(7):821-827. PubMed ID: 29949399
[TBL] [Abstract][Full Text] [Related]
9. Targeted therapies: what they teach us about the pathogenesis of psoriasis and psoriatic arthritis.
Tan WS; Kelly S; Pitzalis C
Expert Rev Clin Immunol; 2017 Mar; 13(3):207-222. PubMed ID: 27690678
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers and biologics related with psoriasis and psoriatic arthritis.
Gao W; Wang Z; Li W; Li Y; Liu M
Int Immunopharmacol; 2023 Sep; 122():110646. PubMed ID: 37454633
[TBL] [Abstract][Full Text] [Related]
11. An Integrative Approach to Biomarker Development in Psoriatic Arthritis.
Ritchlin CT
J Rheumatol Suppl; 2015 Nov; 93():43-7. PubMed ID: 26523056
[TBL] [Abstract][Full Text] [Related]
12. Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint.
Rahman M; Zaki Ahmad M; Kazmi I; Akhter S; Beg S; Gupta G; Afzal M; Saleem S; Ahmad I; Adil Shaharyar M; Jalees Ahmed F; Anwar F
Curr Drug Discov Technol; 2012 Mar; 9(1):48-62. PubMed ID: 22023258
[TBL] [Abstract][Full Text] [Related]
13. Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis.
Alunno A; Carubbi F; Cafaro G; Pucci G; Battista F; Bartoloni E; Giacomelli R; Schillaci G; Gerli R
Expert Opin Biol Ther; 2015; 15(12):1727-37. PubMed ID: 26653110
[TBL] [Abstract][Full Text] [Related]
14. Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
Stiff KM; Glines KR; Porter CL; Cline A; Feldman SR
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1209-1218. PubMed ID: 30449211
[TBL] [Abstract][Full Text] [Related]
15. New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.
Karczewski J; Dobrowolska A; Rychlewska-Hańczewska A; Adamski Z
Autoimmunity; 2016 Nov; 49(7):435-450. PubMed ID: 27050731
[TBL] [Abstract][Full Text] [Related]
16. Investigational drugs for treating psoriatic arthritis.
Sheane BJ; Chandran V
Expert Opin Investig Drugs; 2014 Jul; 23(7):1001-16. PubMed ID: 24758276
[TBL] [Abstract][Full Text] [Related]
17. New biologics for psoriasis and psoriatic arthritis.
Rozenblit M; Lebwohl M
Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of psoriatic arthritis.
Veale DJ; Fearon U
Lancet; 2018 Jun; 391(10136):2273-2284. PubMed ID: 29893226
[TBL] [Abstract][Full Text] [Related]
19. [Psoriasis and psoriatic arthritis].
Henno A; Rausin A; Malaise M; de la Brassinne M
Rev Med Liege; 2006; 61(5-6):334-40. PubMed ID: 16910258
[TBL] [Abstract][Full Text] [Related]
20. The safety of ustekinumab for the treatment of psoriatic arthritis.
López-Ferrer A; Laiz A; Puig L
Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
